View Older Stories View More Recent Stories

May 11, 2015 08:00AM AbbVie to Present New Data from Studies of Five Oncology Pipeline Assets in Multiple Cancers at the 51st American Society of Clinical Oncology Annual Meeting
May 6, 2015 07:30AM Investigational Medicine Venetoclax Receives Breakthrough Therapy Designation in Relapsed or Refractory Chronic Lymphocytic Leukemia in Previously Treated Patients with the 17p Deletion Genetic Mutati
May 6, 2015 07:00AM AbbVie to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 5, 2015 12:20PM AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy and Safety of HUMIRA® (adalimumab) in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis
May 1, 2015 04:59PM AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Apr 29, 2015 08:00AM AbbVie to Present at Deutsche Bank 40th Annual Health Care Conference
Apr 29, 2015 07:30AM FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Apr 25, 2015 10:00AM AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015
Apr 24, 2015 12:45AM U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C
Apr 23, 2015 07:48AM AbbVie Reports First-Quarter 2015 Financial Results
Apr 17, 2015 04:47PM AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Apr 15, 2015 07:00PM AbbVie's Investigational Chronic Hepatitis C Treatment Granted Priority Review in Japan
Apr 15, 2015 10:05AM AbbVie to Host First-Quarter Earnings Conference Call
Apr 8, 2015 04:19AM AbbVie to Present New Data from Hepatitis C Clinical Development Program at The International Liver Congress™ 2015
Apr 1, 2015 02:17PM AbbVie CF Scholarship Application for Students with Cystic Fibrosis Now Available for 2015-2016 Academic School Year
Mar 27, 2015 07:00AM European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Mar 19, 2015 08:44AM AbbVie And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy
Mar 17, 2015 08:00AM AbbVie's Dermatology Leadership Showcased with HUMIRA® (adalimumab) Data at American Academy of Dermatology 2015 Annual Meeting
Mar 6, 2015 08:00AM AbbVie to Present at Barclays Global Health Care Conference
Feb 9, 2015 12:06PM Streetinsider.com's Hot Lunchtime Reads 2/9: (AMD) (TWTR) (KORS) (GOOG)
Oct 21, 2014 10:23AM Notable Analyst Rating Changes 10/21: (GPOR) (ILMN) (POST) Upgraded; (ABBV) (IBM) (BHP) Downgraded
Sep 8, 2014 12:45PM FTC Files Complaint Against AbbVie (ABBV), Besins Over Delays to Generic AndroGel
Jul 18, 2014 10:11AM Notable Mergers and Acquisitions of the Day 07/18: (GTIV) (ABBV)/(SHPG) (TWTR) (RDNT)
Dec 10, 2013 02:42PM Notable 52-Week Highs and Lows of the Day 12/10: (CIM) (TWTR) (CVS) High; (BURL) (EW) (FIO) Low
View More Recent Stories View Older Stories